Cancer Therapies
Tamoxifen Not Harmful to Endothelial Function
Published in Women's Health Weekly, May 6th, 2000
Scientists say that despite tamoxifen's estrogen agonist and antagonist characteristics, the drug is not harmful to endothelial function in postmenopausal breast cancer patients. Group 1: Recently diagnosed breast cancer patients Group 2: Patients who had been receiving long-term tamoxifen Group 3: Breast cancer patients in remission who did not take tamoxifen
To assess the potentially negative effect of tamoxifen on the cardiovascular system, Paul J.L. Ong and colleagues designed a study of 22 postmenopausal women with breast cancer. The women fell into one of three groups:
Ong et al. assessed Group 1 both...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Obstetrics
Much Ado About a Little Cut: Is Episiotomy Worthwhile? - Bone Metastasis
Pamidronate Therapy Reduces Skeletal Complications in Metastatic Breast Cancer - Cancer Gene Therapy
p53-Mediated Growth Suppression Enhanced By Chemotherapy - Eating Disorders
Study Addresses Nonweight-Related Body Image - Epidemiology
Overweight a Serious Problem in Developing Countries - Leukemia
Bioflavonoids May Contribute to DNA Damage Leading to Disease in Infants - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
